In Vitro Activities of Rifamycin Derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and Recent Clinical Isolates of Chlamydia pneumoniae

類似資料

• In Vitro Anti-Helicobacter pylori Activities of New Rifamycin Derivatives, KRM-1648 and KRM-1657
  著者:: Akada, Junko K., 等
  出版事項: (1999)
• Emergence of Resistance to Rifampin and Rifalazil in Chlamydophila pneumoniae and Chlamydia trachomatis
  著者:: Kutlin, Andrei, 等
  出版事項: (2005)
• In Vitro Activities of BMS-284756 against Chlamydia trachomatis and Recent Clinical Isolates of Chlamydia pneumoniae
  著者:: Malay, Sheila, 等
  出版事項: (2002)
• In vitro and in vivo antibacterial activities of KRM-1648 and KRM-1657, new rifamycin derivatives.
  著者:: Fujii, K, 等
  出版事項: (1994)
• In Vitro Activities of Gemifloxacin (SB 265805, LB20304) against Recent Clinical Isolates of Chlamydia pneumoniae
  著者:: Roblin, Patricia M., 等
  出版事項: (1999)